Fine-needle aspiration of a Xp11.2 translocation/TFE3 fusion renal cell carcinoma metastatic to the lung: Report of a case and review of the literature

Diagnostic Cytopathology

Volumn 34, Issue 11, 2006, Pages 751-756

  Schinstine, Malcolm ^a   Filie, Armando C ^a   Torres Cabala, Carlos ^a   Abati, Andrea ^a   Linehan, W Marston ^b   Merino, Maria ^b  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cytology; FNA; Kidney; TFE3

Indexed keywords

PROTEIN XP11.2; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR TFE3; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; ASPIRATION BIOPSY; CASE REPORT; CELL VACUOLE; CHROMOSOME TRANSLOCATION; CHROMOSOME XP; CLEAR CELL CARCINOMA; COMPUTER ASSISTED DIAGNOSIS; FEMALE; GENE FUSION; GENE TRANSLOCATION; HISTOPATHOLOGY; HUMAN; HYALINE DEGENERATION; IMMUNOCYTOCHEMISTRY; KIDNEY BIOPSY; KIDNEY CARCINOMA; KIDNEY PAPILLA; LUNG METASTASIS; NEPHRECTOMY; ONCOGENE; PRIORITY JOURNAL; REVIEW; TFE3 GENE; TUMOR BIOPSY; XP11 2 GENE;

BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; BIOPSY, FINE-NEEDLE; CARCINOMA, RENAL CELL; CHROMOSOMES, HUMAN, X; FEMALE; HUMANS; KIDNEY NEOPLASMS; LUNG NEOPLASMS; MIDDLE AGED; TRANSLOCATION, GENETIC;

EID: 33750515675     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.20548     Document Type: Review

References (26)

1. Argani P, Antonescu CR, Couturier J, et al. PRCC-TFE3 renal carcinomas. Morphological, immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t(X:1)(p11.2;q21). Am J Surg Pathol 2002;26:1553-1566.
2. Meloni AM, Dobbs RM, Pontes JE, Sandberg AA. Translocation (X:1) in papillary renal cell carcinoma. A new cytogenetic subtype. Cancer Genet Cytogenet 1993;65:1-6.
3. Argani P, Antonescu CR, Illei PB, et al. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma. A dinstinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol 2001;159:179-192.
4. Argani P, Landanyi M. Recent advances in pediatric renal neoplasia. Adv Anal Pathol 2003;10:243-260.
5. Argani P, Landanyi M. Translocation carcinomas of the kidney. Clin Lab Med 2005;25:363-378.
6. Eble JN, Sauter G, Epstein JI, et al., editors. Tumors of the kidney. In: WHO classification of tumors: Tumors of the urinary system and male genital organs. Lyon, France: IARC Press; 2004.
7. Bodmer D, van den Hurk W, van Groningen JJM, et al. Understanding familial and non-familial renal cell cancer. Hum Mol Genet 2002;20:2489-2498.
8. Steingrimmson E, Copeland NG, Jenkins NA. Melanocytes and the Microphthalmia transcription factor network. Annu Rev Genet 2004;38:365-411.
9. Verastegui C, Berlolotto C, Bille K, et al. TFE3, a transcription factor homologous to microphthalmia, is a potential transcriptional activator of tyrosinase and Tyrp1 genes. Mol Endocrinol 2000;14:449-456.
10. Heimann P, Housin HEH, Ogur G, et al. Fusion of a novel gene, RCC17, to the TFE3 gene in t(X:17)(p11.2;q25.3)-bearing papillary renal cell carcinomas. Cancer Res 2001;61:4130-4135.
11. Sidhar SK, Clark J, Gill S, et al. The t(X:1)(p11.2;q21.1) translocation in papillary renal cell carcinoma fuses a novel gene PRCC to the TFE3 transcription factor gene. Hum Mol Genet 1996;5:1333-1338.
12. Weterman MAJ, Wilbrink M, van Kessel AG. Fusion of the transcription factor TFE3 gene to a novel gene, PRCC, in t(X;1) (p11;q21)-positive papillary renal cell carcinomas. Proc Natl Acad Sci USA 1996;93:15294-15298.
13. Argani P, Lui MY, Couturier J, et al. A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X:17)(p11.2:q23). Oncogene 2003;22:5374-5378.
14. Tomlinson GE, Nisen PD, Timmons CF, et al. Cytogenetics of a renal cell carcinoma in a 17-month-old child. Evidence for Xp11.2 as a recurring breakpoint. Cancer Genet Cytogenet 1991;57:11-17.
15. Skalsky YM, Ajuh PM, Parker C, et al. PRCC, the commonest TFE3 fusion partner in papillary renal carcinoma is associated with the pre-mRNA splicing factors. Oncogene 2001;20:178-187.
16. nrb) to the TFE3 gene in papillary renal cell carcinoma. Oncogene 1997;15:2233-2239.
17. Chian-Garcia CA, Torres-Cabala CA, Eyler R, et al. Renal cell carcinoma in children and young adults: A clinicopathological and immunohistochemical study of 14 cases. Mod Pathol 2003;16:145A.
18. Argani P, Ladanyi M. Distinctive neoplasms characterized by specific chromosomal translocations comprise a significant proportion of paediatric renal cell carcinomas. Pathology 2003;35:492-498.
19. Argani P, Lal P, Hutchinson B, et al. Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions. A sensitive and specific immunohistochemical assay. Am J Surg Pathol 2003;27:750-761.
20. Roma AA, Yang B, Senior ME, Goldblum JR. TFE3 immunoreactivity in alveolar soft part sarcoma of the uterine cervix: Case report. Int J Gynecol Pathol 2005;24:131-135.
21. Zhu C, Melamed J, Sidhu G, et al. The alveolar soft parts sarcoma marker TFE3 is also frequently expressed in granular cell tumor. Mod Pathol 2005;18:93A.
22. Mai KT, Alhalouly T, Lamba M, et al. Distribution of subtypes of metastatic renal-cell carcinoma: Correlating findings of fine-needle aspiration biopsy and surgical pathology. Diagn Cytopathol 2003;28:66-70.
23. McGregor DK, Khurana KK, Cao C, et al. Diagnosing primary and metastatic renal cell carcinoma. The use of monoclonal antibody 'renal cell carcinoma marker'. Am J Surg Pathol 2002;25:1485-1492.
24. Yang B, Ali SZ, Rosenthal DL. CD10 facilitates the diagnosis of metastatic renal cell carcinoma from primary adrenal cortical neoplasm in adrenal fine-needle aspiration. Diagn Cytopathol 2002;27:149-152.
25. Bruder E, Passera O, Harms D, et al. Morphological and molecular characterization of renal cell carcinoma in children and young adults. Am J Surg Pathol 2004;9:1117-1132.
26. Torres-Cabala CA, Linehan WM, Merino MJ. Renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusions. Check Sample, Surgical Pathology 11, No. SPII 05-7 (SPII-299), Chicago: ASCP Press; 2005.